Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

163045 ARTíCULOS , VIENDO DEL 76 AL 90

PUBMED

Intranasal amyloid model of Alzheimer's disease - potential opportunities and challenges

Singh RK.

Pharmacol Rep. 2025 Apr;77(2):425-433. doi: 10.1007/s43440-024-00692-4. Epub 2025 Jan 8.

0

0

0

PUBMED

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

Alsaleem MA, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alrouji M, Al-Harchan NA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.

0

0

0

PUBMED

Tetrameric Transthyretin as a Protective Factor Against Alzheimer's Disease

Corino C, Aimo A, Luigetti M, Ciccone L, Ferrari Chen YF, Panichella G, Musetti V, Castiglione V, Vergaro G, Emdin M, Franzini M.

Mol Neurobiol. 2025 Mar;62(3):2945-2954. doi: 10.1007/s12035-024-04442-8. Epub 2024 Aug 27.

0

0

0

PUBMED

Exploring neurosurgical interventions in Alzheimer's disease: current perspectives and future directions

Kathiresan N, Selvaraj C, Subbaraj GK, Langeswaran K.

Neurol Sci. 2025 Apr;46(4):1925-1927. doi: 10.1007/s10072-024-07925-7. Epub 2024 Dec 10.

0

0

0

PUBMED

Treatments of psychosomatic symptoms in Alzheimer's disease: a scoping review of the potential therapeutic effects of essential oils

Abdulghani MF, Barzegari R, Almagharbeh WT, Yazdani Z, Amandadi Ghotbabadi A, Seyed Bagheri SH, Alnaiem M, Dehghan M.

Psychogeriatrics. 2025 Mar;25(2):e70007. doi: 10.1111/psyg.70007.

0

0

0

PUBMED

A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease

Fuseya K, Mimura Y, Nakajima S, Mimura M, Kasanuki K, Noda Y.

J Alzheimers Dis. 2025 May;105(1):28-43. doi: 10.1177/13872877251325887. Epub 2025 Mar 20.

0

0

0

PUBMED

Leveraging mHealth wearables for managing patients with Alzheimer's disease: a scoping review

Noda K, Kageyama I, Kobayashi Y, Lim Y, Sengoku S, Kodama K.

Drug Discov Today. 2025 May;30(5):104363. doi: 10.1016/j.drudis.2025.104363. Epub 2025 Apr 16.

0

0

0

PUBMED

Population-Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study

Desai RJ, Varma VR, Mahesri M, Lee SB, Freedman A, Gerhard T, Segal J, Vine S, Ritchey MBE, Horton DB, Thambisetty M.

Clin Pharmacol Ther. 2025 Apr;117(4):1039-1050. doi: 10.1002/cpt.3583. Epub 2025 Feb 11.

0

0

0

PUBMED

Interplay between PI3k/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implications

Bhatia V, Vikram V, Chandel A, Rattan A.

Inflammopharmacology. 2025 Apr;33(4):1785-1802. doi: 10.1007/s10787-025-01715-z. Epub 2025 Mar 15.

0

0

0

PUBMED

Advancing Remote Monitoring for Patients With Alzheimer Disease and Related Dementias: Systematic Review

Shaik MA, Anik FI, Hasan MM, Chakravarty S, Ramos MD, Rahman MA, Ahamed SI, Sakib N.

JMIR Aging. 2025 May 14;8:e69175. doi: 10.2196/69175.

0

0

0

PUBMED

Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation

Liu Y, Aquili L, Wong KH, Lu Z, Lim LW.

Ageing Res Rev. 2025 Jun;108:102755. doi: 10.1016/j.arr.2025.102755. Epub 2025 Apr 14.

0

0

0

PUBMED

Potential therapeutic targets for Alzheimer's disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy

Li Y, Yang C, Liu X, Shu J, Zhao N, Sun Z, Tabish MS, Hong Y, Liu E, Wei N, Sun M.

Neuroscience. 2025 May 7;573:42-51. doi: 10.1016/j.neuroscience.2025.03.009. Epub 2025 Mar 15.

0

0

0

PUBMED

Knowing the enemy: strategic targeting of complement to treat Alzheimer disease

Tenner AJ, Petrisko TJ.

Nat Rev Neurol. 2025 May;21(5):250-264. doi: 10.1038/s41582-025-01073-y. Epub 2025 Mar 24.

0

0

0

PUBMED

Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial

Kutzsche J, Cosma NC, Kauselmann G, Fenski F, Bieniek C, Bujnicki T, Pils M, Bannach O, Willbold D, Peters O.

Nat Commun. 2025 May 6;16(1):4180. doi: 10.1038/s41467-025-59295-z.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy